ARTICLE | Company News
ImevaX, Technical University Munich infectious news
December 8, 2014 8:00 AM UTC
The university spun out ImevaX to develop vaccines against pathogens of chronic and nosocomial infectious disease. ImevaX’s lead candidate, IMX101, is a recombinant vaccine against Helicobacter pylor...